Marion McCourt has an estimated net worth of $35.8 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., Axovant Sciences Ltd., SCYNEXIS INC, and MEDIVATION, INC..

2022 was Marion McCourt's most active year for acquiring shares with 16 total transactions. Marion McCourt's most active month to acquire stocks was the month of November. 2022 was Marion McCourt's most active year for disposing of shares, totalling 30 transactions. Marion McCourt's most active month to dispose stocks was the month of November. 2024 saw Marion McCourt paying a total of $2,415,033.52 for 17,725 shares, this is the most they've acquired in one year. In 2023 Marion McCourt cashed out on 23,752 shares for a total of $13,118,624.28, their largest year based on trade value.